Handelsbanken Fonder AB - FIBROGEN INC ownership

FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 144 filers reported holding FIBROGEN INC in Q1 2017. The put-call ratio across all filers is 3.06 and the average weighting 0.2%.

Quarter-by-quarter ownership
Handelsbanken Fonder AB ownership history of FIBROGEN INC
ValueSharesWeighting
Q3 2023$16
-67.3%
18,0880.0%0.00%
Q2 2023$49
-85.5%
18,0880.0%0.00%
-100.0%
Q1 2023$338
+16.6%
18,0880.0%0.00%0.0%
Q4 2022$290
-99.9%
18,0880.0%0.00%0.0%
Q3 2022$235,000
+23.0%
18,0880.0%0.00%
+100.0%
Q2 2022$191,000
-30.3%
18,088
-20.6%
0.00%
-50.0%
Q1 2022$274,000
-14.6%
22,7880.0%0.00%0.0%
Q4 2021$321,000
+63.8%
22,788
+18.8%
0.00%
+100.0%
Q3 2021$196,000
-61.6%
19,1880.0%0.00%
-66.7%
Q2 2021$511,000
-5.5%
19,188
+23.1%
0.00%0.0%
Q1 2021$541,000
-88.0%
15,588
-87.2%
0.00%
-88.9%
Q4 2020$4,510,000
-9.8%
121,5880.0%0.03%
-27.0%
Q3 2020$5,000,000
-48.2%
121,588
-48.9%
0.04%
-9.8%
Q2 2020$9,646,000
+222.8%
237,976
+176.7%
0.04%
-35.9%
Q1 2020$2,988,000
+5.5%
86,000
+30.3%
0.06%
+30.6%
Q4 2019$2,831,000
-60.9%
66,000
-66.3%
0.05%
-66.7%
Q3 2019$7,248,000
-29.0%
196,000
-13.3%
0.15%
-22.2%
Q2 2019$10,211,000
-29.4%
226,000
-15.0%
0.19%
-32.5%
Q1 2019$14,457,000
-10.1%
266,000
-23.4%
0.28%
-13.6%
Q4 2018$16,078,000
-30.4%
347,400
-8.6%
0.32%
+14.1%
Q3 2018$23,084,000
+114.4%
380,000
+120.9%
0.28%
+34.6%
Q2 2018$10,767,000
-29.8%
172,000
-48.2%
0.21%
+31.9%
Q1 2018$15,338,000
-1.4%
332,000
+1.2%
0.16%
-13.5%
Q4 2017$15,548,000
-27.4%
328,000
-17.6%
0.18%
-31.2%
Q3 2017$21,412,000
+177.4%
398,000
+66.5%
0.27%
+36.5%
Q2 2017$7,720,000
+31.0%
239,0000.0%0.20%
+20.1%
Q1 2017$5,891,000
+38.3%
239,000
+20.1%
0.16%
+26.2%
Q4 2016$4,259,000
+3.4%
199,0000.0%0.13%
+7.4%
Q3 2016$4,119,000
+325.5%
199,000
+237.3%
0.12%
+202.5%
Q2 2016$968,000
+1.0%
59,000
+31.1%
0.04%
-2.4%
Q1 2016$958,000
-60.7%
45,000
-43.8%
0.04%
-12.8%
Q4 2015$2,438,00080,0000.05%
Other shareholders
FIBROGEN INC shareholders Q1 2017
NameSharesValueWeighting ↓
Vantage Consulting Group Inc 605,713$9,703,5225.73%
ARMISTICE CAPITAL, LLC 3,864,000$61,901,2801.08%
Logos Global Management LP 525,000$8,410,5000.98%
5AM Venture Management, LLC 225,583$3,613,8400.97%
Intercontinental Wealth Advisors, LLC 191,300$3,064,6260.91%
BHK Investment Advisors, LLC 87,550$1,402,5510.79%
Integral Health Asset Management, LLC 175,000$2,803,5000.59%
Nan Fung Group Holdings Ltd 34,106$546,3780.38%
Soleus Capital Management, L.P. 113,463$1,817,6770.26%
Point72 Asset Management, L.P. 4,781,645$76,601,9530.26%
View complete list of FIBROGEN INC shareholders